|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent APRE insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why APRE insider buys are important for investors to follow.
Date | Insider | Price | Amount |
10-23-2024 Insider Buy |
Oren Gilad President/CEO |
$3.92
CAGR »
|
$1,957.50 500 shares |
10-16-2024 Insider Buy |
Marc Duey Director |
$4.39
CAGR »
|
$131,700.00 30,000 shares |
10-11-2024 Insider Buy |
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr |
$2.46
CAGR »
|
$123.19 50 shares |
10-14-2024 Insider Buy |
Marc Duey Director |
$2.58
CAGR »
|
$490.20 190 shares |
10-15-2024 Insider Buy |
Oren Gilad President/CEO |
$2.90
CAGR »
|
$725.00 250 shares |
10-10-2024 Insider Buy |
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr |
$2.61
CAGR »
|
$1,174.50 450 shares |
10-14-2024 Insider Buy |
Oren Gilad President/CEO |
$2.58
CAGR »
|
$2,971.00 1,150 shares |
10-11-2024 Insider Buy |
Bernd R. Seizinger Director |
$2.68
CAGR »
|
$26,800.00 10,000 shares |
3-13-2024 Insider Buy |
Oren Gilad President, CEO |
$7.29
CAGR »
|
$14,580.00 2,000 shares |
3-13-2024 Insider Buy |
John B. Henneman III Director |
$7.29
CAGR »
|
$50,009.40 6,860 shares |
3-13-2024 Insider Buy |
Bernd R. Seizinger Director |
$7.29
CAGR »
|
$50,009.40 6,860 shares |
3-13-2024 Insider Buy |
John P. Hamill SrVP/CFO/Prin Fin & Acct Ofcr |
$7.29
CAGR »
|
$7,362.90 1,010 shares |
6-7-2023 Insider Buy |
Bernd R. Seizinger Director |
$3.66
CAGR »
|
$36,956.55 10,097 shares |
10-7-2019 Insider Buy |
5AM Ventures IV, L.P. >10% Owner |
$15.00
CAGR »
|
$4,999,995.00 333,333 shares |
10-7-2019 Insider Buy |
Redmile Group, LLC >10% Owner |
$15.00
CAGR »
|
$6,000,000.00 400,000 shares |
10-7-2019 Insider Buy |
HealthCap VII, L.P. >10% Owner |
$15.00
CAGR »
|
$4,000,005.00 266,667 shares |
10-7-2019 Insider Buy |
Scott M. Coiante SVP, Chief Financial Officer |
$15.00
CAGR »
|
$37,500.00 2,500 shares |
10-7-2019 Insider Buy |
Eyal C. Attar SVP, Chief Medical Officer |
$15.00
CAGR »
|
$6,000.00 400 shares |
10-7-2019 Insider Buy |
Gregory Alan Korbel VP of Business Dev't |
$15.00
CAGR »
|
$7,500.00 500 shares |
10-7-2019 Insider Buy |
John B. Henneman III
|
$15.00
CAGR »
|
$75,000.00 5,000 shares |
10-7-2019 Insider Buy |
Guido Magni
|
$15.00
CAGR »
|
$97,500.00 6,500 shares |
10-7-2019 Insider Buy |
Johan Christenson
|
$15.00
CAGR »
|
$4,000,005.00 266,667 shares |
10-7-2019 Insider Buy |
V. Luxco S.A R.L. Versant
|
$15.00
CAGR »
|
$4,999,995.00 333,333 shares |
10-7-2019 Insider Buy |
Versant Vantage I, L.P.
|
$15.00
CAGR »
|
$4,999,995.00 333,333 shares |
10-7-2019 Insider Buy |
Christian S. Schade President & CEO |
$15.00
CAGR »
|
$165,000.00 11,000 shares |
Also See: Institutional Holders of APRE
Also See: SEC filings
Below we present the annualized performance delivered by APRE stock since 10-23-2024 (the date of the most recent
insider purchase). The performance of the investment from the time APRE insider buying occurred is the ultimate
test of whether insiders were right about APRE being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/24/2024 |
|
End date: |
01/14/2025 |
|
Start price/share: |
$3.90 |
|
End price/share: |
$3.62 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-7.18% |
|
Annualized Gain: |
-31.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9,282.00 |
|
Years: |
0.22 |
|
APRE Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent APRE insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding APRE
|
|